Tag
This paper proposes JoPMol, a jointly controlled precision molecular generative model that integrates gene expression profiles, molecular structure text, and chemical properties to generate personalized drug candidates, outperforming state-of-the-art methods.
CAPABLE is an AI-driven lab that can go from drug design to data in 24 hours, starting with short-sleeper peptides. The project aims to turn AI capabilities into human capabilities for drug development.
Anthropic announced Claude Science, an AI workbench for scientists, and revealed its own plans to develop drugs for neglected diseases using AI, entering a competitive field of AI-driven drug discovery.
Anthropic is launching an internal AI drug discovery program to develop treatments for neglected diseases, aiming to improve its AI tools for drugmakers and join tech giants in the healthcare market.
The article profiles chemist Tim Cernak, who applies AI-driven drug design (like AlphaFold) to develop precision treatments for wildlife, coining the field 'conservation chemistry' to address mass extinction with cutting-edge tools.
DeepMind's Co-Scientist AI helped identify two repurposed medicines that block liver fibrosis in lab tests, including a cancer drug that blocked 91% of a damage response, outperforming human expert selections.
Demis Hassabis claims AI can cure all diseases within 10 years, backed by a $2.1B funding round for Isomorphic Labs to accelerate AI-driven drug discovery and personalized medicine.
Isomorphic Labs, an AI-driven drug discovery company founded by Demis Hassabis, announced a $2.1 billion Series B funding round led by Thrive Capital to scale its business and advance its AI drug design engine, IsoDDE.
Dell Technologies highlights how AI is accelerating drug discovery and improving patient outcomes through their AI Factory partnership with NVIDIA, offering tailored solutions for enterprise adoption.